دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores
Filippo Crea
doi : 10.1093/eurheartj/ehac802
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 167–170
Preprints: a game changer in scientific publications?
Fernando Alfonso, Filippo Crea
doi : 10.1093/eurheartj/ehac665
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 171–173
Meet Habib Gamra: new European Heart Journal co-editor for North Africa
Judith Ozkan
doi : 10.1093/eurheartj/ehac668
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 174–175
The ‘10 commandments’ for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The 2022 ESC Guidelines for the management of patients with ventricular arrhythmias (VAs) and the prevention of sudden cardiac death (SCD) present an update of the 2015 guidelines.
Jacob Tfelt-Hansen, Bo Gregers Winkel, Marta de Riva, Katja Zeppenfeld
doi : 10.1093/eurheartj/ehac699
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 176–177
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges
Massimo Volpe, Carlo Patrono
doi : 10.1093/eurheartj/ehac649
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 178–179
Association between basic life support and survival in sports-related sudden cardiac arrest: a meta-analysis
Laurianne Michelland, Mohammad H Murad, Wulfran Bougouin, Mark Van Der Broek, Larry J Prokop, Soraya Anys, Marie-Cécile Perier, Alain Cariou, Jean Philippe Empana, Eloi Marijon, Xavier Jouven, Patricia Jabre
doi : 10.1093/eurheartj/ehac586
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 180–192
To evaluate the association of basic life support with survival after sports-related sudden cardiac arrest (SR-SCA).
Shocking insights on resuscitation after sports-related cardiac arrest
Domenico Corrado, Alberto Cipriani, Alessandro Zorzi
doi : 10.1093/eurheartj/ehac659
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 193–195
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
Johan Lyth, Emma Svennberg, Lars Bernfort, Mattias Aronsson, Viveka Frykman, Faris Al-Khalili, Leif Friberg, MÃ¥rten Rosenqvist, Johan Engdahl, Lars-Ã…ke Levin
doi : 10.1093/eurheartj/ehac547
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 196–204
Previous studies on the cost-effectiveness of screening for atrial fibrillation (AF) are based on assumptions of long-term clinical effects. The STROKESTOP study, which randomised 27 975 persons aged 75/76 years into a screening invitation group and a control group, has a median follow-up time of 6.9 years.
Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag
Erica S Spatz, Jeph Herrin
doi : 10.1093/eurheartj/ehac696
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 205–207
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
Ziad Hijazi, Alexander P Benz, Johan Lindbäck, John H Alexander, Stuart J Connolly, John W Eikelboom, Christopher B Granger, Peter Kastner, Renato D Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin
doi : 10.1093/eurheartj/ehac632
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 208–218
Biomarkers specifically related to atrial tissue may increase the understanding of the pathophysiology of atrial fibrillation (AF) and further improve risk prediction in this setting.
A specific new biomarker for atrial fibrillation and its sequelae?
Moritz F Sinner, Aenne S von Falkenhausen
doi : 10.1093/eurheartj/ehac645
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 219–220
A polygenic risk score predicts atrial fibrillation in cardiovascular disease
Nicholas A Marston, Amanda C Garfinkel, Frederick K Kamanu, Giorgio M Melloni, Carolina Roselli, Petr Jarolim, David D Berg, Deepak L Bhatt, Marc P Bonaca, Christopher P Cannon, Robert P Giugliano, Michelle L O’Donoghue, Itamar Raz, Benjamin M Scirica, Eugene Braunwald, David A Morrow, Patrick T Ellinor, Steven A Lubitz, Marc S Sabatine, Christian T Ruff
doi : 10.1093/eurheartj/ehac460
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 221–231
Interest in targeted screening programmes for atrial fibrillation (AF) has increased, yet the role of genetics in identifying patients at highest risk of developing AF is unclear.
Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure
Stefan Kääb, Hilma Holm, Paulus Kirchhof
doi : 10.1093/eurheartj/ehac527
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 232–234
Are there other factors that influence the assessment of bleeding risk comparing potent P2Y12 inhibitors with clopidogrel?
Cheng Xie, Yuzhen Zhang, Jia Lin
doi : 10.1093/eurheartj/ehac598
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Page 235
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot
Mattia Galli, Luis Ortega-Paz, Dominick J Angiolillo
doi : 10.1093/eurheartj/ehac601
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Page 236
First in man: sealing the distal re-entry tears of aortic dissection after thoracic endovascular aortic repair by an ENDOPATCHâ„¢ system
Long Cao, Hongpeng Zhang, Wei Guo
doi : 10.1093/eurheartj/ehac676
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Page 237
Cardiac tamponade caused by intrapericardial diaphragmatic hernia
Yi-Min Gu, Long-Qi Chen
doi : 10.1093/eurheartj/ehac682
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Page 238
